sch 34826 has been researched along with naltrexone in 4 studies
| Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (naltrexone) | Trials (naltrexone) | Recent Studies (post-2010) (naltrexone) |
|---|---|---|---|---|---|
| 31 | 2 | 0 | 8,745 | 1,228 | 2,642 |
| Protein | Taxonomy | sch 34826 (IC50) | naltrexone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0051 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0063 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.006 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.0319 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0093 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0377 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0076 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herz, A; Parsons, CG | 1 |
| Conti, A; Marzanatti, M; Monopoli, A; Ongini, E; Trampus, M | 1 |
| Innes, DG; Kavaliers, M | 1 |
| Galea, LA; Innes, DG; Kavaliers, M; Kinsella, DM; Ossenkopp, KP; Perrot-Sinal, TS; Prato, FS | 1 |
4 other study(ies) available for sch 34826 and naltrexone
| Article | Year |
|---|---|
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for activation by enkephalin-like opioid peptides after cold water swim stress.
Topics: Analgesia; Animals; Dioxolanes; Dipeptides; Enkephalins; Inflammation; Leucine; Male; Naloxone; Naltrexone; Neprilysin; Rats; Rats, Inbred Strains; Receptors, Opioid; Stress, Physiological; Swimming; Thiorphan | 1990 |
Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat.
Topics: Animals; Dioxolanes; Dioxoles; Dipeptides; Dose-Response Relationship, Drug; Electroencephalography; Male; Morphine; Naltrexone; Neprilysin; Rats; Rats, Inbred Strains; Sleep; Sleep, REM; Thiorphan; Wakefulness | 1990 |
Sex differences in the antinociceptive effects of the enkephalinase inhibitor, SCH 34826.
Topics: Analgesia; Analgesics; Animals; Dioxolanes; Dipeptides; Enkephalin, Leucine; Female; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Peromyscus; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Restraint, Physical; Sex Characteristics; Stress, Psychological | 1993 |
Spatial learning in deer mice: sex differences and the effects of endogenous opioids and 60 Hz magnetic fields.
Topics: Analgesics; Animals; Dioxolanes; Dipeptides; Electromagnetic Fields; Endorphins; Female; Male; Maze Learning; Memory; Naltrexone; Narcotic Antagonists; Peromyscus; Psychomotor Performance; Sex Characteristics | 1996 |